TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies-Reference-Cited by-同舟云学术

TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies

Published:2022-06 Issue:6 Volume:3 Page:100640
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

van der Ploeg Kattria^ORCID,Kirosingh Adam S.,Mori Diego A.M.,Chakraborty Saborni,Hu Zicheng,Sievers Benjamin L.,Jacobson Karen B.,Bonilla Hector,Parsonnet Julie,Andrews Jason R.,Press Kathleen D.,Ty Maureen C.,Ruiz-Betancourt Daniel R.,de la Parte Lauren,Tan Gene S.,Blish Catherine A.,Takahashi Saki,Rodriguez-Barraquer Isabel,Greenhouse Bryan,Singh Upinder,Wang Taia T.,Jagannathan Prasanna^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference66 articles.

1. T cell responses in patients with COVID-19;Chen;Nat. Rev. Immunol.,2020

2. Targets of T Cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals;Grifoni;Cell,2020

3. Adaptive immunity to SARS-CoV-2 and COVID-19;Sette;Cell,2021

4. Serial SARS-CoV-2 receptor-binding domain antibody responses in patients receiving dialysis;Anand;Ann. Intern. Med.,2021

5. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection;Cromer;Nat. Rev. Immunol.,2021

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD4 ⁺ and CD8 ⁺ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment;Science Advances;2024-08-23

2. Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria;Cell Reports;2024-08

3. Evaluation of an RBD-nucleocapsid fusion protein as a booster candidate for COVID-19 vaccine;iScience;2024-07

4. Structural Determinants of Health and Markers of Immune Activation and Systemic Inflammation in Sexual Minority Men With and Without HIV;Journal of Urban Health;2024-06-03

5. A broadly applicable protein-polymer adjuvant system for antiviral vaccines;EMBO Molecular Medicine;2024-05-15